● Single award · contract
Advance the Development of Potent, Cross-Reactive Multispecific Antibodies for the Prep Countermeasure of…
A single federal award, with both ends of the trail linked.
$103.5M
total award value
2023
action date
53 mo
period
75A50123C00056
PIID
Description
Advance the Development of Potent, Cross-Reactive Multispecific Antibodies for the Prep Countermeasure of COVID-19 and Seasonal and Highly Pathogenic Avian Influenza.
Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceMassachusetts →
CategoryNAICS 541714PSC AN13
Competed?Not recorded✓ from source
Total (exact)$103,516,903
More from Department of Health and Human Services
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
awarded 2022$71.7B
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.